Autoinflammatory diseases are conditions where the immune system attacks the body, causing inflammation. Many are caused by a single gene mutation. Doctors often use genetic testing to find the exact cause, hoping it will guide treatment. However, a recent review of existing research suggests that this approach has limits.
The review looked at studies on several types of autoinflammatory diseases, including those caused by problems in the inflammasome (a part of the immune system) and those involving a protein called NF-κB. The authors found that the same genetic mutation can cause very different symptoms in different people. Conversely, different genetic problems can lead to similar symptoms. This means that knowing the specific gene mutation does not reliably tell doctors which organs will be affected or how the patient will respond to treatment.
Instead of relying solely on genetics, the review recommends a broader approach. Treatment decisions should consider the patient's current inflammatory activity, which organs are most affected, the stage of the disease, whether tissue damage can be reversed, and any other health problems. This "phenotype-weighted and organ-prioritized" framework aims to personalize treatment more effectively than genetics alone.
It is important to note that this is a review of existing studies, not a new clinical trial. The authors did not test any specific drugs. Their goal was to highlight the complexity of autoinflammatory diseases and suggest a more practical way to choose treatments.
